UvA Ventures

UvA Ventures Holding B.V. serves as the investment and technology transfer arm of the University of Amsterdam (UvA) in the Netherlands. The company specializes in spinning out academic research into commercially viable enterprises, providing seed capital, business development expertise, and intellectual property management. Within the life sciences and healthcare sectors, UvA Ventures manages a diverse portfolio of startups focusing on drug discovery, medical diagnostics, and digital health. Notable portfolio companies include Macrobian Biotech, which focuses on neurodegenerative diseases, and Incircular, which specializes in protein stabilization. By bridging the gap between scientific innovation and the market, UvA Ventures facilitates the translation of early-stage research into clinical and commercial applications.